Dogwood Therapeutics DWTX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's net change in cash?
- Dogwood Therapeutics (DWTX) reported net change in cash of $6.7M in Q1 2026.
- How has Dogwood Therapeutics's net change in cash changed year-over-year?
- Dogwood Therapeutics's net change in cash increased by 149.2% year-over-year, from $2.69M to $6.7M.
- What is the long-term trend for Dogwood Therapeutics's net change in cash?
- Over 3 years (2021 to 2025), Dogwood Therapeutics's net change in cash has grown at a -19.2% compound annual growth rate (CAGR), from -$15.79M to -$8.33M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.